Unregistered Sales of Equity Securities and Use of Proceeds
−Removed: The following table provides information about purchases of our common shares during the three months ended September 30, 2023.
+Added: The following table provides information about purchases of our common shares during the three months ended March 31, 2024.
Total Number of Shares Purchased Average Price Paid per Share Total number of shares purchased as part of publicly announced plans or programs Maximum number of shares that may be purchased under the plans or programs
−Removed: July 1, 2023 - July 31, 2023 20,500 (1) $ 19.66 20,500 284,236
−Removed: August 1, 2023 - August 31, 2023 — $ — — 742,134 (2)
−Removed: September 1, 2023 - September 30, 2023 41,844 $ 20.24 41,844 700,290
+Added: January 1, 2024 - January 31, 2024 10,314 (1) $ 21.50 10,314 569,223
+Added: February 1, 2024 - February 29, 2024 47,399 (2) $ 22.51 (3) — —
+Added: March 1, 2024 - March 31, 2024 122,750 (1) $ 24.30 122,750 446,473
Total 180,463 $ 23.67 133,064 446,473
−Removed: (1) In August 2022, our Board authorized a common share repurchase program (the 2022 Share Repurchase Program), which expired in August 2023, to repurchase up to 5.0% of our total common shares which are issued and outstanding, or 685,614 common shares, over a twelve month period.
−Removed: We repurchased an aggregate of 20,500 of our common shares outstanding for approximately $0.4 million under the 2022 Share Repurchase Program during the three months ended September 30, 2023.
−Removed: (2) In August 2023, our Board authorized a new common share repurchase program, (the 2023 Share Repurchase Program), which expires August 2024, to repurchase up to 5.0% of our total common shares which are issued and outstanding, or 742,134 common shares over a twelve month period.
−Removed: We repurchased an aggregate of 41,844 of our common shares outstanding for approximately $0.8 million under the 2023 Share Repurchase Program during the three months ended September 30, 2023.
+Added: (1) In August 2023, our Board of Directors authorized a common share repurchase program, which expires in August 2024, to repurchase up to 5.0% of our total common shares which were issued and outstanding at the time of approval, or 742,134 common shares, over a twelve month period.
+Added: We repurchased an aggregate of 133,064 of our common shares outstanding for approximately $3.2 million during the three months ended March 31, 2024.
+Added: (2) Consists of shares surrendered to us by participants in our 2014 Equity Participation Plan to settle the participants' personal tax liabilities that resulted from the lapsing of restrictions on shares awarded to the participants under the plan.
+Added: (3) The price paid per share was based on the closing price of our common shares on February 22, 2024, the respective date as of which the restrictions lapsed on such shares.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.